Continue reading this on our app for a better experience

Open in App
Floating Button
Home Billion-dollar-club Billion Dollar Club 2020

Malaysian glove maker UG Healthcare wins for overall sector

The Edge Singapore
The Edge Singapore • 2 min read
Malaysian glove maker UG Healthcare wins for overall sector
UG Healthcare was named the Centurion Club overall sector winner for Healthcare Services
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

In a sign of how glove makers are enjoying their day in the sun, the Centurion Club overall sector winner for Healthcare Services & Pharmaceuticals goes to another Malaysia-based glove maker, UG Healthcare Corporation. For FY2017 ended June 30, the company recorded earnings of $2.18 million. This number doubled to $4.3 million for FY2018 before halving to $2.2 million the following year. For FY2020, thanks to the supercharged demand for rubber gloves, UG Healthcare was able to report earnings of $15.1 million.

Medtecs International Corporation, which makes personal protective equipment used by healthcare workers, has been named winner for the return to shareholders category. During the evaluation period of up to June 30, the company’s share price surged by a CAGR of 99.3%, with a big chunk of it driven by the gains early this year, as the Covi-19 outbreak ignited demand. It was one of the best performing stocks on the SGX this year.

Tianjin Zhong Xin Pharmaceutical Group Corp, one of the earlier China-based companies to list on the SGX back in 1997, has been named sector winner for showing the best growth in profit after tax. The company, which produces drugs including a handful given top level grading in China. For FY2016 ended Dec 31, 2016, it reported earnings of RMB423.6 million. This number increased to RMB476.1 million and RMB561.7 million for FY2017 and FY2018, and increased yet again to RMB625.6 million in FY2019.

Healthcare player TalkMed Group, meanwhile, has been named sector winner for the best weighted return on equity. The company was incorporated in Sept 2013 and was listed on the Catalist on Jan 30, 2014. While the company’s speciality is in cancer treatment, it has expanded into other medical fields such as stem cell transplants and palliative care. Besides Singapore, it has also expanded into other parts of Asia such as Vietnam and China.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.